CV6 Therapeutics to invest almost £8m in clinical trial for new anti-cancer drug
8th June 2023CV6 Therapeutics is investing almost £8m in first-stage clinical trials and further scientific development work on its first anti-cancer drug CV6-168.
View Case Study